Perceptive Advisors LLC, Director at Astria Therapeutics, Inc. (ATXS), bought 740,000 shares at $6.20 ($4.6M) on 2023-12-21, disclosed to the SEC on 2023-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ACRV | SELL | 2025-05-01 | $2.0M | — | Filing → |
| ACRV | SELL | 2025-04-29 | $5.1M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |